Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis
Advances in Lung Cancer · 2015
DOI: 10.4236/alc.2015.41002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Lung Cancer, 2015. Verfasst von Takashi Yokoi und 9 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yokoi, T., Kurata, T., Torii, Y., Katashiba, Y., Ogata, M., Satsutani, N. M., Niki, M., Katashiba, N. I., Kibata, K. N., & Nomura, S. (2015). Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis. Advances in Lung Cancer. https://doi.org/10.4236/alc.2015.41002
Vancouver
Yokoi T, Kurata T, Torii Y, Katashiba Y, Ogata M, Satsutani NM, et al. Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis. Advances in Lung Cancer. 2015. doi:10.4236/alc.2015.41002
BibTeX
@article{Yokoi2015,
author = {Yokoi, Takashi and Kurata, Takayasu and Torii, Yoshitaro and Katashiba, Yuichi and Ogata, Makoto and Satsutani, Naoko Murakami and Niki, Maiko and Katashiba, Noriko Inagaki and Kibata, Kayoko Nishimura and Nomura, Shosaku},
title = {Efficacy and Safety of Continuing Bevacizumab beyond Disease Progression plus Docetaxel in Patients with Non-Small Cell Lung Cancer: A Retrospective Analysis},
journal = {Advances in Lung Cancer},
year = {2015},
doi = {10.4236/alc.2015.41002}
}
EUVIMED